C

Crown Bioscience, Inc.

511 employees

CrownBio is helping provide clarity of action in the fight against cancer and diabetes.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
PK/PD
Validated Xenograft Models
Oncology
Inflammation
Cancer Cell Based Assays
HuPrime PDX (Patient-Derived Xenograft) models
Human Surrogate (Avatar) Trials - HuTrials
Health Care
Organoids
Oncology Drug Development
Biomarker Discovery
Medical
Drug Development
Immunotherapy platforms

Date founded

2006

Funding rounds raised

Total raised

$29M

from 13 investors over 13 rounds

C

Crown Bioscience, Inc. raised $27M on May 23, 2014

Investors: Majuven, Lilly Asia Ventures and Qiming Venture Partners

C

Crown Bioscience, Inc. raised $29M on May 4, 2011

Investors: Argonaut Private Equity, CDIB Capital International Corporation, Qiming Venture Partners, OrbiMed Advisors and The CID Group

C

Crown Bioscience, Inc. raised $1M on May 1, 2011

Investors: Qiming Venture Partners and CDIB Capital International Corporation

C

Crown Bioscience, Inc. raised $3.2M on March 1, 2008

Investors: Qiming Venture Partners

C

Crown Bioscience, Inc. raised undisclosed on January 1, 2008

Investors: Harbinger Venture and Qiming Venture Partners

FAQ